Teva, Mylan Clarify Copaxone Patent Claims
Teva Pharmaceuticals USA Inc. has clarified that certain infringement allegations don't target Mylan Inc. in a suit filed against the generics maker, its U.S. manufacturer and Natco Pharma Ltd. over a...To view the full article, register now.
Already a subscriber? Click here to view full article